Gemcitabine News and Research

RSS
Gemcitabine is the active ingredient in a drug that is used to treat pancreatic cancer that is advanced or has spread. It is also used together with other drugs to treat breast cancer that has spread, advanced ovarian cancer, and non-small cell lung cancer that is advanced or has spread. It is also being studied in the treatment of other types of cancer. Gemcitabine blocks the cell from making DNA and may kill cancer cells. It is a type of antimetabolite
Scientists identify pathway for treatment-resistant lung cancer

Scientists identify pathway for treatment-resistant lung cancer

Study opens a promising new front in the fight against pancreatic cancer

Study opens a promising new front in the fight against pancreatic cancer

New drug may enhance efficacy of chemotherapy in pancreatic cancer

New drug may enhance efficacy of chemotherapy in pancreatic cancer

The gift of longevity for a pancreatic cancer patient

The gift of longevity for a pancreatic cancer patient

Study shows synergistic effects of drugs that inhibit cell division in pancreatic cancer

Study shows synergistic effects of drugs that inhibit cell division in pancreatic cancer

Targeted pancreatic cancer drug shows promise in clinical trials

Targeted pancreatic cancer drug shows promise in clinical trials

New drug to treat pancreatic cancer shows promising results in clinical trial

New drug to treat pancreatic cancer shows promising results in clinical trial

Longer-lived, but less toxic drug may work better for pancreatic cancer

Longer-lived, but less toxic drug may work better for pancreatic cancer

Promising antibody therapy reduces tumor growth, increases survival in mice with pancreatic cancer

Promising antibody therapy reduces tumor growth, increases survival in mice with pancreatic cancer

Scientists identify new way to target bottleneck for cancer cell growth

Scientists identify new way to target bottleneck for cancer cell growth

Prior radioprotection via EGLN inhibitor improves survival in mouse model of pancreatic cancer

Prior radioprotection via EGLN inhibitor improves survival in mouse model of pancreatic cancer

Tumor-associated macrophages block activity of chemotherapy drug in pancreatic cancer

Tumor-associated macrophages block activity of chemotherapy drug in pancreatic cancer

Researchers identify marker protein that offers both diagnostic and therapeutic function

Researchers identify marker protein that offers both diagnostic and therapeutic function

Study assesses safety and efficacy of new treatment for pancreatic cancer

Study assesses safety and efficacy of new treatment for pancreatic cancer

Toxic effects of drugs in the lungs 'more widespread than thought'

Toxic effects of drugs in the lungs 'more widespread than thought'

Study: Erlotinib improves progression-free survival in EGFR mutated NSCLC

Study: Erlotinib improves progression-free survival in EGFR mutated NSCLC

Study: Sarcoma patients poorly informed about risk of interactions with anti-cancer drugs

Study: Sarcoma patients poorly informed about risk of interactions with anti-cancer drugs

Researchers design new medicine to treat highly aggressive pancreatic cancer

Researchers design new medicine to treat highly aggressive pancreatic cancer

Finding which chemotherapy regimen is associated with best outcomes for patients with bladder cancer

Finding which chemotherapy regimen is associated with best outcomes for patients with bladder cancer

Trial shows PARP inhibitor as novel treatment option for patients with advanced breast cancers

Trial shows PARP inhibitor as novel treatment option for patients with advanced breast cancers